[Clinical evaluation of timentin in intensive care]. / Evaluation clinique du timentin en réanimation.
Pathol Biol (Paris)
; 34(5): 448-50, 1986 May.
Article
en Fr
| MEDLINE
| ID: mdl-3534719
ABSTRACT
16 patients admitted to a MICU were treated with timentin (ticarcillin + clavulanic acid) for bacterial infections 11 cases of pulmonary infection, 3 cases of urinary tract infection, 2 septic shocks, 3 septicemias and 1 case of multifocal infection. The pathogens considered as a firmly established cause of infection were 5 Acinetobacter, 12 Pseudomonas, 3 Serratia, 4 Klebsiella, 1 E. coli, 2 Proteus, 1 Providencia, 1 Staphylococcus aureus, 1 Staphylococcus epidermidis, 1 Streptococcus D and 1 Flavobacterium meningosepticum. The susceptibility of these pathogens to ticarcillin and timentin is reported. Timentin was prescribed alone in 9 cases and associated (with an aminoglycoside) in 7, in a daily dose of 9 to 18 g, for 6 to 45 days. 3 patients died. The value of timentin in infections due to multiresistant MICU pathogens is stressed.
Buscar en Google
Bases de datos:
MEDLINE
Métodos Terapéuticos y Terapias MTCI:
Plantas_medicinales
Asunto principal:
Penicilinas
/
Ticarcilina
/
Infecciones Bacterianas
/
Ácidos Clavulánicos
Idioma:
Fr
Revista:
Pathol Biol (Paris)
Año:
1986
Tipo del documento:
Article